Research Insights

Research Insights section focuses on the cutting-edge and breakthrough research that is happening all over the world. Laboratories across the globe are working hard to develop drugs and therapies for various diseases and research insights directly from them add tremendous value.

Qualitative study to conceptualise a model of interprofessional collaboration between pharmacists and general practitioners to support patients' adherence to medication

Abstract Objectives Pharmacists and general practitioners GPs face an increasing expectation to collaborate interprofessionally on a number of healthcare issues including medication nonadherence This study aimed to propose a model of interprofessional collaboration within the context of identifying and improvi

Using the Consumer Experience with Pharmacy Services Survey as a quality metric for ambulatory care pharmacies: older adults' perspectives

Abstract Objectives To describe older adults perceptions of evaluating and comparing pharmacies based on the Consumer Experience with Pharmacy Services Survey CEPSS describe older adults perceived importance of the CEPSS and its specific domains and explore older adults perceptions of the i

Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre

Abstract Objectives To identify consumer information needs about paracetamol the most commonly used analgesic and antipyretic worldwide Design Retrospective analysis of medicines questions from the public Set

When procedures meet practice in community pharmacies: qualitative insights from pharmacists and pharmacy support staff

Abstract Objectives Our aim was to explore how members of community pharmacy staff perceive and experience the role of procedures within the workplace in community pharmacies Setting Community pharmacies in England and Wales

General understanding on physical stability of pharmaceutical glasses

Although amorphous solid dispersion is one of the most important formulation technologies for poorly soluble drugs the number of marketed oral amorphous formulations is still limited The lack of an accelerated study protocol for predicting crystallization behavior of amorphous forms has been one of the biggest issues that inhibit their wide use Is...

Electrochemical studies for the determination of an antibiotic drug, D-cycloserine, in pharmaceutical and human biological samples

Abstract An antibiotic drug Dcycloserine CYS in phosphate buffer at different pH values was electrochemically studied using a gold electrode A wellresolved irreversible diffusioncontrolled voltammetric peak was obtained at V in a pH phosphate buffer solution with an ionic strength of M The experimental conditions such as the solution pH

Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies

Abstract Governments that procure pharmaceutical products from an Essential Medicine List EML bear special responsibility for the quality of these products In this article we examine the possibility of developing a pharmaceutical product quality risk assessment scheme for use by government procurement officials We use the Chinese EML as a basis an...

Pharmaceutical interfaces: Drug development, performance, regulation and e-health

Interfaces have always been of concern with respect to the delivery of bioactives Interfaces within the delivery system that can affect stability are a concern however there are other interfaces of importance such as the interface with the body tissue the regulatory interface and the emerging interface when drug delivery is linked to ehealth applic...

Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units

Abstract Objective Clinical Pharmacy Services CPS are considered standard of care and is endorsed by the Joint Commission International the American Academy of Pediatrics and the American College of Clinical Pharmacy In Brazil single experiences have been discreetly arising and the importance of these s

New frontiers in pharmaceutical analysis: A metabolomic approach to check batch compliance of complex products based on natural substances

Abstract Natural substances particularly medicinal plants and their extracts are still today intended as source for new Active Pharmaceutical Ingredients APIs Alternatively they can be validly employed to prepare medicines food supplements or medical devices The most adopted analytical approach used to verify quality of natural substances like med...